Authors: MCLAUGHLIN P GRILLOLOPEZ AJ LINK BK LEVY R CZUCZMAN MS WILLIAMS ME HEYMAN MR BENCEBRUCKLER I WHITE CA CABANILLAS F JAIN V HO AD LISTER J WEY K SHEN D DALLAIRE BK

Citation: P. Mclaughlin et al., RITUXIMAB CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY FOR RELAPSEDINDOLENT LYMPHOMA - HALF OF PATIENTS RESPOND TO A 4-DOSE TREATMENT PROGRAM, Journal of clinical oncology, 16(8), 1998, pp. 2825-2833

Authors: MCLAUGHLIN P CABANILLAS F GRILLOLOPEZ AJ LINK BK LEVY R CRUCZMAN M HEYMAN MR WILLIAMS M JAIN W BENCEBRUCKLER I HO AD LISTER J ROSENBERG J DALLAIRE BK SHEN D

Citation: P. Mclaughlin et al., IDEC-C2B8 ANTI-CD20 ANTIBODY - FINAL REPORT ON A PHASE-III PIVOTAL TRIAL IN PATIENTS (PTS) WITH RELAPSED LOW-GRADE OR FOLLICULAR LYMPHOMA (LG F NHL)/, Blood, 88(10), 1996, pp. 349-349

Authors: MCLAUGHLIN P CABANILLAS F GRILLOLOPEZ AJ LINK GL LEVY R CRUCZMAN M HEYMAN MR WILLIAMS M JAIN V BENCEBRUCKLER L HO AD LISTER J WEY K SHUEY S PARKER E

Citation: P. Mclaughlin et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF THE ANTI-CD20 ANTIBODY (MAB) IDEC-C2B8 IN PATIENTS (PTS) WITH RELAPSED LOW-GRADE OR FOLLICULAR LYMPHOMA (LG F NHL)/, Blood, 88(10), 1996, pp. 350-350

Authors: CABANILLAS F GRILLOLOPEZ AJ MCLAUGHLIN P LINK BK LEVY R CZUCZMAN M HEYMAN MR WILLIAMS M JAIN V BENCEBRUCKLER I HO AD LISTER J ROGER J SHEN D VARNS C

Citation: F. Cabanillas et al., ANTI-CD20 ANTIBODY (MAB), IDEC-C2B8 - CLEARANCE OF BCL-2 T(14-18) POSITIVE CELLS FROM PERIPHERAL-BLOOD (PB) AND BONE-MARROW (BM) IN PATIENTS (PTS) WITH RELAPSED LOW-GRADE OR FOLLICULAR LYMPHOMA (LG F NHL)/, Blood, 88(10), 1996, pp. 351-351

Authors: LEFOR AT FLOWERS JL HEYMAN MR

Citation: At. Lefor et al., LAPAROSCOPIC STAGING OF HODGKINS-DISEASE, Surgical oncology, 2(3), 1993, pp. 217-220